KAZIA THERAPEUTICS LIMITED.
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
Kazia Initiates Preparatory Activities to Bring GDC-0084 into GBM AGILE, an International Phase II / III Study in Glioblastoma 2019-12-11 08:41
Positive Interim Efficacy Data from GDC-0084 Phase II Study in Glioblastoma Released at SNO Conference 2019-11-25 07:00
Kazia Raises A$4.0 Million to Progress R&D Programs 2019-10-28 10:16
Kazia wins ANZLF Trans-Tasman Innovation & Growth Award and reports new data from clinical trial in childhood brain cancer 2019-09-13 20:00
St Jude Study of GDC-0084 in DIPG Successfully Completes First Stage; Second Part of Study Now Underway 2019-09-12 21:10
Kazia to test GDC-0084 with Radiotherapy in Phase I Clinical Trial at Leading US Cancer Center 2019-07-22 09:08
Kazia calls for greater awareness of the deadliest brain cancer in the US 2019-07-17 20:00
Kazia Enters Clinical Collaboration for Metastatic Brain Cancer with Alliance for Clinical Trials in Oncology 2019-05-20 11:41
Kazia calls for greater awareness of the deadliest gynecological cancer in the US 2019-05-08 20:00
Kazia calls for greater awareness of the most lethal women's disease in Australia 2019-05-08 09:55
Kazia Presents Positive Cantrixil Phase I Data at AACR Conference 2019-04-01 11:29
Kazia to present on Cantrixil at American Association for Cancer Research (AACR) 2019 Annual Meeting 2019-03-25 13:25
Kazia Share Purchase Plan Raises A$0.8 Million, Taking Total Funds Raised to A$4.2 Million 2018-11-20 12:53
Progress Update on GDC-0084 Program 2018-10-29 18:00
Kazia Enters Clinical Collaboration to Investigate Use of Brain Cancer Drug GDC-0084 in Breast Cancer 2018-10-22 18:00
Kazia Raises A$3.4 Million to Progress R&D Programs 2018-10-18 09:21
Cantrixil Phase I Study Progresses To Next Stage 2018-10-10 15:15
Kazia Releases Preliminary Cantrixil Phase I Data 2018-06-19 18:00
Commencement Of Phase II Clinical Study Of GDC-0084 2018-03-29 08:33
Kazia Receives FDA Orphan Designation for GDC-0084 2018-02-23 17:20
1 2 3 4 5 7